Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Takeda to pay Bayer $155 million over hemophilia drug

      Takeda to pay Bayer $155 million over hemophilia drug

      Medical Dialogues Bureau6 Feb 2019 9:15 AM IST
      Jurors in the federal court in Wilmington, Delaware, reached their verdict on the seventh day of a trial after rejecting Baxalta’s argument that the...
      China watchdog disciplines 80 officials linked to major vaccine scandal

      China watchdog disciplines 80 officials linked to major vaccine scandal

      Medical Dialogues Bureau6 Feb 2019 9:00 AM IST
      Changchun Changsheng Biotechnology, a major Chinese manufacturer of rabies vaccines was slapped with a USD 1.3 billion fine last October after it was...
      Graphene-based Biosensor could diagnose lung cancer early

      Graphene-based Biosensor could diagnose lung cancer early

      Medical Dialogues Bureau5 Feb 2019 9:05 AM IST
      The device, described in the journal Nanoscale, displays the potential to identify specific lung cancer markers at the earliest possible stage. It...
      Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

      Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva

      Medical Dialogues Bureau4 Feb 2019 9:15 AM IST
      “We are pleased that all three companies have chosen Emgality to be one of the preferred medications, making it accessible to even more patients...
      Novartis Kymriah wins UK backing after initial lymphoma snub

      Novartis Kymriah wins UK backing after initial lymphoma snub

      Medical Dialogues Bureau3 Feb 2019 10:00 AM IST
      "Today's positive announcement regarding access to Kymriah treatment in England and Wales was secured as a result of our close working collaboration...
      Dr Reddys Q3 profit up by 45 per cent at Rs 485 crore

      Dr Reddy's Q3 profit up by 45 per cent at Rs 485 crore

      Medical Dialogues Bureau3 Feb 2019 9:45 AM IST
      Though Dr Reddy's was able to book a healthy profit during the quarter, revenues from North America declined by eight per cent despite new product...
      Dr Reddys, KKR appoints Shikha Sharma as independent director, advisor respectively

      Dr Reddy's, KKR appoints Shikha Sharma as independent director, advisor respectively

      Medical Dialogues Bureau3 Feb 2019 9:00 AM IST
      New Delhi: Listed in esteemed publications, such as Asia’s 50 Power Business Women 2012, Most Powerful Indians 2012 and Power List of 25 Most...
      Dabur gets new CEO, Mohit Malhotra to take charge from April

      Dabur gets new CEO, Mohit Malhotra to take charge from April

      Medical Dialogues Bureau2 Feb 2019 9:30 AM IST
      As a result of this process, Mr Mohit Malhotra was found to be suitable as a successor to Mr Duggal. Therefore, on the recommendation of the...
      5 Things to Start Doing as Soon as You Start Earning for a Wealthy Future

      5 Things to Start Doing as Soon as You Start Earning for a Wealthy Future

      Medical Dialogues Bureau1 Feb 2019 5:05 PM IST
      Starting with the first job, most of us wish to be wealthy. Every day, as we wake up and get ready for the grind, we keep pushing ourselves, thinking...
      Ajanta Pharma reports 54.63 percent fall in profit, shares tank

      Ajanta Pharma reports 54.63 percent fall in profit, shares tank

      Medical Dialogues Bureau1 Feb 2019 1:44 PM IST
      Speaking about the drop, Ajanta Pharma Managing Director Yogesh Agrawal informed: "This quarter was a bit challenging for the company which was the...
      Cancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby Powder

      Cancer Causing Asbestos Threat: Sri Lanka halts imports of Johnson & Johnson Baby Powder

      Medical Dialogues Bureau1 Feb 2019 12:51 PM IST
      COLOMBO (Reuters) - Sri Lanka has halted imports of Johnson & Johnson Baby Powder until the company proves its product is free from cancer-causing...
      Pfizer quarterly profit in line, touts pipeline of future products

      Pfizer quarterly profit in line, touts pipeline of future products

      Medical Dialogues Bureau31 Jan 2019 9:05 AM IST
      On a call with analysts, new Chief Executive Albert Bourla said Pfizer had "the best pipeline in our history," and predicted that the company would...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok